SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

A broad crypto selloff, alongside concerns that hot inflation could delay rate cuts, has pushed XRP toward and briefly below key psychological support. Traders are split between warning of further losses and treating the decline as a buying opportunity, while some point to Bitcoin-led weakness and liquidations.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff has traders debating whether the decline will deepen or find support, with bearish calls and panic selling countered by dip buyers citing oversold conditions and a possible rebound. Traders point to rising yields and the dollar, inflation and rate concerns, and ETF outflows as potential headwinds, though the discussion offers no single confirmed trigger.

Toshi (TOSHI) is a cryptocurrency launched in 2023and operates on the BNB Smart Chain (BEP20) platform. Toshi has a current supply of 420,689,980,957.1672248 with 420,658,159,904.11664294 in circulation. The last known price of Toshi is 0.00008433 USD and is down -3.48 over the last 24 hours. It is currently trading on 271 active market(s) with $3,064,413.31 traded over the last 24 hours. More information can be found at https://www.toshithecat.com/.

TOSHI

TOSHI is drawing attention amid a prolonged decline and weak altcoin sentiment, with traders debating whether the token is near a bottom or headed to further lows. Many holders say they are buying the dip and expect a rebound, while others cite poor price action and remain pessimistic; no specific confirmed catalyst dominates.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the FDAs decision on ivonescimab for EGFR-mutated lung cancer, a high-stakes catalyst that traders view as a binary approval-versus-CRL event. The debate centers on strong progression-free-survival results versus the trials lack of statistically significant overall-survival data and the FDAs stated OS requirement; the recent share-price weakness has prompted speculation about a negative outcome, while others argue the data still support approval.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigels Q3 results and sharp share-price pullback are driving discussion: traders are weighing an EPS miss and concerns about the outlook against profitability and Veppanus early sales. Bulls see Veppanus launch as a growth engine, while skeptics question how quickly sales will ramp and flag execution risks around R289 ahead of clinical data.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd.

Teva- Pharmaceutical Industries Ltd. - ADR

Tevas run to fresh 52-week highs is drawing attention as traders focus on its growth pipeline and an expected FDA decision on at-home Igalmi, alongside recent analyst target increases. Sentiment is broadly bullish, though some traders are watching for a pullback after the sharp advance.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,079,719,016.041028 in circulation. The last known price of Algorand is 0.08513994 USD and is down -2.94 over the last 24 hours. It is currently trading on 586 active market(s) with $61,102,468.95 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

Algorands pullback is fueling debate over whether support has failed, with bearish traders warning of further downside and holders arguing the dip is an accumulation opportunity. The discussion also includes optimism about Algorands quantum-security and tokenization potential, but no clear new catalyst is established.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celesticas strong quarterly results and aggressive forward outlook are being weighed against a sharp selloff in AI hardware stocks. Bulls view the demand outlook as intact, while skeptics point to cash-flow needs, thin margins, customer concentration and the risk of slower AI infrastructure spending.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

The FAAs nationwide flight ground stop, attributed to an air-traffic-control communications issue, has prompted traders to discuss whether the disruption underscores demand for cybersecurity and resilient networks. Some speculate about a cyber angle, but traders also note that no attack has been confirmed.

First Majestic Silver Corp. engages in the production, development, exploration, and acquisition of mineral properties, with a focus on silver and gold production in North America. It owns and operates producing mines in Mexico, including the Santa Elena Silver & Gold Mine, the Los Gatos Silver Mine, the San Dimas Silver & Gold Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA, which is currently in the process of restarting. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

AG is being discussed amid weakness in silver and mining shares, with traders pointing to rising yields and expectations of a more hawkish Fed as pressure on precious metals. The community is split between expecting further downside and treating the pullback as a buying opportunity ahead of a possible silver rebound.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

About UROV